Home | All trials

[RDF data]
Trial NCT00000358

Resource URI: http://static.linkedct.org/resource/trials/NCT00000358
PropertyValue
linkedct:brief_title Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
linkedct:collaborator_agency <http://static.linkedct.org/resource/collabagency/8837>
linkedct:condition <http://static.linkedct.org/resource/condition/12664>
linkedct:condition <http://static.linkedct.org/resource/condition/9249>
linkedct:criteria Please contact site for information.
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers No
linkedct:eligibility_maximum_age 59 Years
linkedct:eligibility_minimum_age 21 Years
linkedct:enrollment 0 (xsd:int)
linkedct:firstreceived_date September 20, 1999
linkedct:id NCT00000358
rdfs:label Trial NCT00000358
linkedct:lastchanged_date June 23, 2005
linkedct:lead_sponsor_agency National Institute on Drug Abuse (NIDA)
linkedct:location <http://static.linkedct.org/resource/location/160264>
linkedct:nct_id NCT00000358
linkedct:number_of_arms 0 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title Safety Evaluation of Lofexidine for Treatment of Opioid Withdrawal
linkedct:org_study_id NIDA-3-0012-7
linkedct:overall_official <http://static.linkedct.org/resource/overall_official/8640>
linkedct:overall_status Completed
linkedct:oversight <http://static.linkedct.org/resource/oversight/2918>
foaf:page <http://clinicaltrials.gov/show/NCT00000358>
linkedct:phase Phase 1
linkedct:secondary_id Y01-3-0012-7
linkedct:source National Institute on Drug Abuse (NIDA)
linkedct:study_design Treatment
linkedct:study_type Interventional
linkedct:summary The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.
rdf:type linkedct:trials
linkedct:verification_date December 2002